Schedule of The effect of this restatement on the line items included in our condensed financial statements |
The effect of this restatement on the line items included in our condensed consolidated financial statements for our fiscal quarter ended May 31, 2021, is as follows:
|
|
|
|
|
|
|
|
|
|
|
May 31, 2021
|
|
|
As
|
|
|
|
|
|
|
|
Previously
|
|
|
|
As
|
|
|
Reported
|
|
Adjustments
|
|
Restated
|
Prepaid expenses and other current assets
|
|
$
|
738,000
|
|
(155,000)
|
|
$
|
583,000
|
Deferred Offering Costs - SPACs
|
|
|
—
|
|
48,083,000
|
|
|
48,083,000
|
Total Assets
|
|
|
22,139,000
|
|
47,928,000
|
|
|
70,067,000
|
Noncontrolling interests in consolidated subsidiaries
|
|
|
—
|
|
47,472,000
|
|
|
47,472,000
|
Total Equity (Deficit)
|
|
|
22,139,000
|
|
47,928,000
|
|
|
70,067,000
|
Revenues – three months ended May 31, 2021
|
|
|
2,648,000
|
|
6,827,000
|
|
|
9,475,000
|
Cost of revenues – three months ended May 31, 2021
|
|
|
3,095,000
|
|
6,827,000
|
|
|
9,922,000
|
Gross profit – three months ended May 31, 2021
|
|
|
(447,000)
|
|
—
|
|
|
(447,000)
|
Revenues – nine months ended May 31, 2021
|
|
|
7,570,000
|
|
6,827,000
|
|
|
14,397,000
|
Cost of revenues – nine months ended May 31, 2021
|
|
|
7,141,000
|
|
6,827,000
|
|
|
13,968,000
|
Gross profit - nine months ended May 31, 2021
|
|
|
429,000
|
|
—
|
|
|
429,000
|
|
|
|
|
|
|
|
|
|
Three months ended May 31, 2021:
|
|
|
|
|
|
|
|
|
Operating expenses – Professional fees
|
|
|
1,585,000
|
|
(456,000)
|
|
|
1,129,000
|
All other operating expenses
|
|
|
5,972,000
|
|
—
|
|
|
5,972,000
|
Total Operating expenses
|
|
|
7,557,000
|
|
(456,000)
|
|
|
7,101,000
|
|
|
|
|
|
|
|
|
|
Nine months ended May 31, 2021:
|
|
|
|
|
|
|
|
|
Operating expenses – Professional fees
|
|
|
3,298,000
|
|
(456,000)
|
|
|
2,842,000
|
All other operating expenses
|
|
|
16,713,000
|
|
—
|
|
|
16,713,000
|
Total Operating expenses
|
|
|
20,011,000
|
|
(456,000)
|
|
|
19,555,000
|
|
|
|
|
|
|
|
|
|
Net loss – three months ended May 31, 2021
|
|
|
7,984,000
|
|
(456,000)
|
|
|
7,528,000
|
Net loss – nine months ended May 31, 2021
|
|
|
21,103,000
|
|
(456,000)
|
|
|
20,647,000
|
|
|
|
|
|
|
|
|
|
Net loss per share, basic and diluted
|
|
|
|
|
|
|
|
|
Continuing operations for the 3 months ended May 31, 2021
|
|
|
(0.24)
|
|
0.02
|
|
|
(0.22)
|
Continuing operations for the 9 months ended May 31, 2021
|
|
|
(0.60)
|
|
0.01
|
|
|
(0.59)
|
|
|
|
|
|
|
|
|
|
Cash used in operations
|
|
|
(15,272,000)
|
|
611,000
|
|
|
(14.661,000)
|
Cash provided by financing operations
|
|
|
21,764,000
|
|
(611.000)
|
|
|
21,153,000
|
|